Thomas K. Equels, Executive Vice Chairman/CEO/Pres at HEMISPHERX BIOPHARMA INC (HEB), bought 58,808 shares at $4.03 ($237K) on 2019-06-21, disclosed to the SEC on 2019-06-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.03 | 29,404 | $118K | 50.0% |
| 2 | $4.03 | 29,404 | $118K | 50.0% |
| Total | $4.03 avg | 58,808 | $237K | 100% |
| Filing → |
| AIM | BUY | 2020-12-17 | $25K | — | Filing → |
| AIM | BUY | 2020-09-03 | $25K | — | Filing → |
| AIM | BUY | 2020-08-21 | $25K | — | Filing → |